Scientific paper - Original scientific paper
Prognostic significance of survivin and Caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP
Pathology Oncology Research, 17 (2011), 2; 243-247. https://doi.org/10.1007/s12253-010-9304-4

Mitrović, Zdravko; Ilić, Ivana; Aurer, Igor; Bašić-Kinda, Sandra; Radman, Ivo; Dotlić, Snježana; Ajduković, Radmila; Labar, Boris

Cite this document

Mitrović, Z., Ilić, I., Aurer, I., Bašić Kinda, S., Radman, I., Dotlić, S. ... Labar, B. (2011). Prognostic significance of survivin and Caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP. Pathology Oncology Research, 17. (2), 243-247. doi: 10.1007/s12253-010-9304-4

Mitrović, Zdravko, et al. "Prognostic significance of survivin and Caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP." Pathology Oncology Research, vol. 17, no. 2, 2011, pp. 243-247. https://doi.org/10.1007/s12253-010-9304-4

Mitrović, Zdravko, Ivana Ilić, Igor Aurer, Sandra Bašić Kinda, Ivo Radman, Snježana Dotlić, Radmila Ajduković and Boris Labar. "Prognostic significance of survivin and Caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP." Pathology Oncology Research 17, no. 2 (2011): 243-247. https://doi.org/10.1007/s12253-010-9304-4

Mitrović, Z., et al. (2011) 'Prognostic significance of survivin and Caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP', Pathology Oncology Research, 17(2), pp. 243-247. doi: 10.1007/s12253-010-9304-4

Mitrović Z, Ilić I, Aurer I, Bašić Kinda S, Radman I, Dotlić S, and sur.. Prognostic significance of survivin and Caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP. Pathology Oncology Research [Internet]. 2011 June [cited 2024 June 18];17(2):243-247. doi: 10.1007/s12253-010-9304-4

Z. Mitrović, et al., "Prognostic significance of survivin and Caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP", Pathology Oncology Research, vol. 17, no. 2, pp. 243-247, June 2011. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:221136. [Accessed: 18 June 2024]

Please login to the repository to save this object to your list.